Skip to main content
OpenTrials

Clinical trial condition

Dyskinesias

Explore clinical trials studying Dyskinesias. Study availability and eligibility vary by location and protocol.

123 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Dyskinesias trial results

Completed

ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

NCT01336088

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • Addex Investigator Site Birmingham, Alabama, United States
  • Addex Investigator Site Phoenix, Arizona, United States
  • Addex Investigator Site La Jolla, California, United States
  • Addex Investigator Site Los Angeles, California, United States
View all 25 locations
View Trial Details
Completed

A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease

NCT01149811

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • CNS Network, Inc. Torrance, California, United States
  • University of South Florida Tampa, Florida, United States
  • Advanced Neurodiagnostic Center Metairie, Louisiana, United States
  • Quest Research Institute Bingham Farms, Michigan, United States
View Trial Details
Completed

Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy

NCT00099268

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Mayo Clinic Scottsdale, Arizona, United States
  • Coastal Neurological Medical Group La Jolla, California, United States
  • Keck School of Medicine, Division of Movement Disorders Los Angeles, California, United States
View all 73 locations
View Trial Details
Completed

A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa

NCT01140841

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • CNS Network, Inc. Torrance, California, United States
  • Quest Research Institute Bingham Farms, Michigan, United States
  • Clinical Research Integrity Worldwide LLC Willingboro, New Jersey, United States
  • Duke University Medical Center Durham, North Carolina, United States
View Trial Details
Completed

Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)

NCT00632762

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • Hôpital d'Aix en Provence Aix-en-Provence, France
  • CHU de Clermont-Ferrand Clermont-Ferrand, France
  • CHU Timone Marseille, France
  • Hôpital Haut-Lévêque Nantes, France
View Trial Details
Completed

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa

NCT00582673

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +11 more
Locations
  • Novartis Investigator Site Dresden, Germany
  • Novartis Investigator Site Kassel, Germany
  • Novartis Investigator Site Leun, Germany
  • Novartis Investigator Site Marburg, Germany
View Trial Details

Related conditions